Optic neuropathies in childhood: a review of etiology and treatment

Optic neuropathy (ON) is a common problem in childhood resulting fromvarious causes including ischemic, metabolic, hereditary, traumatic andinflammatory events. The latter represents the most prevalent group; the term“optic neuritis” is generally used for this group which can manifest as part ofa systemic inflammatory disease, a central nervous system disorder, or as anisolated entity. The aim of this review is to highlight the clinical characteristicsand treatments of ON for pediatricians, focusing on optic neuritis.

___

1. Biousse V, Newman NJ. Ischemic optic neuropathies. N Engl J Med 2015; 372: 2428-2436.

2. Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol 2007; 1: 233-246.

3. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991; 109: 1673-1678.

4. Lapeyraque AL, Haddad E, Andre JL, et al. Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis. Am J Kidney Dis 2003; 42: E3-E9.

5. Kim JS, Deputy S, Vives MT, Aviles DH. Sudden blindness in a child with end-stage renal disease. Pediatr Nephrol 2004; 19: 691-693.

6. Matalia J, Kasturi N, Anaspure HD, Shetty BK. Tonic pupil, anterior ischemic optic neuropathy in a teenager with Takayasu arteritis. Can J Ophthalmol 2013; 48: e159-e163.

7. Partal A, Moshfeghi DM, Alcorn D. Churg-Strauss syndrome in a child: retina and optic nerve findings. Br J Ophthalmol 2004; 88: 971-972.

8. Di Zazzo G, Guzzo I, De Galasso L, et al. Anterior ischemic optical neuropathy in children on chronic peritoneal dialysis: report of 7 cases. Perit Dial Int 2015; 35: 135-139.

9. Hayati AA, Wan-Hitam WH, Cheong MT, Yunus R, Shatriah I. Optic neuritis in a child with biotinidase deficiency: case report and literature review. Clin Ophthalmol 2012; 6: 389-395.

10. McAbee GN, Prieto DM, Kirby J, Santilli AM, Setty R. Permanent visual loss due to dietary vitamin A deficiency in an autistic adolescent. J Child Neurol 2009; 24: 1288-1289.

11. Van Stavern GP. Metabolic, hereditary, traumatic, and neoplastic optic neuropathies. Continuum (Minneap Minn) 2014; 20(4 Neuro-ophthalmology): 877-906.

12. Mascialino B, Leinonen M, Meier T. Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe. Eur J Ophthalmol 2012; 22: 461-465.

13. Newman NJ, Biousse V, Newman SA, et al. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. Am J Ophthalmol 2006; 141: 1061-1067.

14. Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol 2015; 9: 1165-1176.

15. Carelli V, Carbonelli M, de Coo IF, et al. International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy. J Neuroophthalmol 2017; 37: 371-381.

16. Skidd PM, Lessell S, Cestari DM. Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+. Semin Ophthalmol 2013; 28: 422-426.

17. Barboni P, Valentino ML, La Morgia C, et al. Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. Brain 2013; 136(Pt 2): e231.

18. Van Stavern GP, Biousse V, Lynn MJ, Simon DJ, Newman NJ. Neuro-ophthalmic manifestations of head trauma. J Neuroophthalmol 2001; 21: 112-117.

19. Ford RL, Lee V, Xing W, Bunce C. A 2-year prospective surveillance of pediatric traumatic optic neuropathy in the United Kingdom. J AAPOS 2012; 16: 413-417.

20. Cakmakli G, Kurne A, Guven A, et al. Childhood optic neuritis: the pediatric neurologist's perspective. Eur J Paediatr Neurol 2009; 13: 452-457.

21. Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006; 67: 258-262.

22. Pahor D. Bilateral optic neuritis in a child following Epstein-Barr virus infection. Coll Antropol 2005; 29(Suppl 1): 129-132.

23. Mansor AM, Li HK. Cytomegalovirus optic neuritis: characteristics, therapy and survival. Ophthalmologica 1995; 209: 260-266.

24. Choi SY, Choi YJ, Choi JH, Choi KD. Isolated optic neuritis associated with Mycoplasma pneumoniae infection: report of two cases and literature review. Neurol Sci 2017; 38: 1323-1327.

25. Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy 2014; 4: 134-141.

26. Venkatesh P, Garg SP, Verma L, et al. Combined optic neuropathy and central retinal artery occlusion in miliary tuberculosis. Retina 2001; 21: 375-377.

27. Moradian S, Ahmadieh H. Early onset optic neuritis following measles-rubella vaccination. J Ophthalmic Vis Res 2008; 3: 118-122.

28. Erguven M, Guven S, Akyuz U, Bilgiç O, Laloglu F. Optic neuritis following hepatitis B vaccination in a 9-year-old girl. J Chin Med Assoc 2009; 72: 594-597.

29. Sugita K, Ando M, Minamitani K, Miyamoto H, Niimi H. Magnetic resonance imaging in a case of mumps postinfectious encephalitis with asymptomatic optic neuritis. Eur J Pediatr 1991; 150: 773-775.

30. Farris BK, Pickard DJ. Bilateral postinfectious optic neuritis and intravenous steroid therapy in children. Ophthalmology 1990; 97: 339-345.

31. Topaloglu H, Berker M, Kansu T, Saatci U, Renda Y. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet 1992; 339: 178-179.

32. Dos Passos GR, Oliveira LM, da Costa BK, et al. MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol 2018; 9: 217.

33. Carnero Contentti E, De Virgiliis M, Hryb JP, et al. Aquaporin-4 serostatus and visual outcomes in clinically isolated acute optic neuritis. J Neuroophthalmol 2019; 39: 165-169.

34. Lee CG, Lee B, Lee J, Lee M. The natural course of clinically isolated syndrome in pediatric patients. Brain Dev 2015; 37: 432-438.

35. Heussinger N, Kontopantelis E, Gburek-Augustat J, et al; for GRACE-MS (German-speaking Research Alliance for ChildrEn with Multiple Sclerosis). Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol 2015; 77: 1076-1082.

36. Drori T, Chapman J. Diagnosis and classification of neuromyelitis optica (Devic's syndrome). Autoimmun Rev 2014; 13: 531-533.

37. Tenembaum S, Chitnis T, Nakashima I, et al. Neuromyelitis optica spectrum disorders in children and adolescents. Neurology 2016; 87(9 Suppl 2): S59-S66.

38. Wingerchuk DM, Banwell B, Bennett JL, et al; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177-189.

39. Krupp LB, Tardieu M, Amato MP, et al; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19: 1261-1267.

40. Waldman A, Ness J, Pohl D, et al. Pediatric multiple sclerosis: Clinical features and outcome. Neurology 2016; 87(9 Suppl 2): S74-S81.

41. Averseng-Peaureaux D, Mizzi M, Colineaux H, et al; Kidbiosep Study Group. Paediatric optic neuritis: factors leading to unfavourable outcome and relapses. Br J Ophthalmol 2018; 102: 808-813.

42. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000; 123(Pt 12): 2407-2422.

43. Kidd D, Burton B, Plant GT, Graham EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 2003; 126(Pt 2): 276-284.

44. Petzold A, Plant GT. Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 2014; 261: 17-26.

45. Beck RW, Cleary PA, Anderson MM Jr, et al; The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992; 326: 581-588.

46. Beck RW, Cleary PA, Trobe JD, et al; The Optic Neuritis Study Group. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993; 329: 1764- 1769.

47. Collinge JE, Sprunger DT. Update in pediatric optic neuritis. Curr Opin Ophthalmol 2013; 24: 448-452.

48. Gal RL, Vedula SS, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev 2015; 8: CD001430.

49. Viswanathan S, Wong AH, Quek AM, Yuki N. Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica. J Neuroimmunol 2015; 282: 92-96.

50. Roed HG, Langkilde A, Sellebjerg F, et al. A doubleblind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology 2005; 64: 804-810.

51. Koziolek M, Mühlhausen J, Friede T, et al. Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease. Blood Purif 2013; 36: 92-97.

52. Jacquet C, Garnier A, Cheuret E. Plasma exchange and immunoadsorption in pediatric inflammatory optic neuropathy resistant to corticosteroid therapy: Four French cases. Neuropediatrics 2016; 47: 175- 178.

53. Deschamps R, Gueguen A, Parquet N, et al. Plasma exchange response in 34 patients with severe optic neuritis. J Neurol 2016; 263: 883-887.

54. Black JA, Liu S, Hains BC, Saab CY, Waxman SG. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 2006; 129(Pt 12): 3196-3208.

55. Lo AC, Saab CY, Black JA, Waxman SG. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 2003; 90: 3566-3571.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

Relationships between screen time, internet addiction and other lifestyle behaviors with obesity among secondary school students in the Turkish Republic of Northern Cyprus

Özen AŞUT, Gulifeiya ABUDUXİKE, Songül Acar VAİZOĞLU, Şanda ÇALI

What triggered massive hemoptysis in Goodpasture syndrome with isolated pulmonary involvement in a 14-year-old boy?

Tuğba Şişmanlar EYÜBOĞLU, Ayşe Tana ASLAN, Deniz Gezgin YILDIRIM, Necla BUYAN, Serhat EMEKSİZ, Gökhan KALKAN

Expression of the Toll-like receptors 2 gene as a genetic determinant of the formation of newborns multiple organ failure syndrome

Dmytro A. SHKURUPİİ

Cranial MR characteristics of Cerebral Palsy cases and correlation of findings with clinical results

Asuman ALİ, Ramazan YALÇIN, Ayşem Ünlüer GÜMÜŞTAŞ

Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a probable mutation in SPINK5 C

Kemal ÖZYURT, Mustafa ATASOY, Ragıp ERTAŞ, Yılmaz ULAŞ, Muhammed Reşat AKKUŞ, Aslıhan KİRAZ, Hans Christian HENNİES

The case of pyridoxine dependent epilepsy misdiagnosed as non-ketotic hyperglycinemia

Hande Gazeteci TEKİN, Melis DEMİR, Gül AKTAN, Hasan TEKGÜL, Sarenur GÖKBEN

Reversible cardiomyopathy-tachycardiomyopathy in children

Alev ARSLAN, İlkay ERDOĞAN, Birgül VARAN, Mustafa YILMAZ, Mehmet Bülent ÖZİN, Niyazi Kürşad TOKEL

Unusual and early onset IPEX syndrome: a case report

Dilek DOĞRUEL, Fatih GÜRBÜZ, İhsan TURAN, Derya Ufuk ALTINTAŞ, Mustafa YILMAZ, Bilgin YÜKSEL

Medicolegal evaluation of a maternal filicide attempt: a case report

Dilşad Foto ÖZDEMİR, Aysun Balseven ODABAŞI, Özlem TEKŞAM, Ferda KARADAĞ, Ramazan AKCAN, Eda YILMAZ

An adolescent case of extensive Behçet’s disease successfully treated with Infliximab

Emel ISIYEL, Sevcan BAKKALOĞLU, Deniz OĞUZ, İdil YENİCESU, Öznur BOYUNAĞA, Yeşim ÖZDEMİR, Çağrı DAMAR, Yaşar KANDUR, Meltem AKÇABOY, Ayşe Tana ASLAN, Tuğba ŞİŞMANLAR, Enver HASANOĞLU, Necla BUYAN